Brand against brand · semaglutide and liraglutide

Wegovy vs Saxenda

From the two FDA labels, read Published by PepVault

Wegovy is semaglutide, a GLP-1 receptor agonist, from Novo Nordisk; Saxenda is liraglutide, a GLP-1 receptor agonist, from Novo Nordisk.

FDA approved Wegovy for weight loss and keeping it off, lowering heart risk in adults with heart disease and excess weight, and (the injection) the liver disease MASH. Saxenda is approved for weight loss and keeping it off, in adults and in children 12 and older with obesity.

Label against label

Wegovy and Saxenda, from their FDA labels and Drugs@FDA
ComparedWegovySaxenda
Active ingredientsemaglutideliraglutide
ClassGLP-1 receptor agonistGLP-1 receptor agonist
MakerNovo NordiskNovo Nordisk
Approved forWeight reduction; heart risk with obesity; MASH (injection)Weight reduction (adults and children 12 and up)
FormsSingle-dose pen; Single-dose syringe; FlexTouch pen; TabletPrefilled pen
How oftenonce a week or once a dayonce a day
Starting dose0.25 mg a week (injection); 1.5 mg a day (tablets)0.6 mg a day
Top dose on the label7.2 mg a week (injection); 25 mg a day (tablets)3 mg a day
Most reported side effectNausea, 44% on 2.4 mg (placebo 16%)Nausea, 39.3% on Saxenda (placebo 13.8%)
Boxed warning“RISK OF THYROID C-CELL TUMORS”“RISK OF THYROID C-CELL TUMORS”
First approved20212014

Each label’s side-effect figure comes from its own trials, at its own doses and in its own patients; as the labels themselves say, rates from different trials can’t be compared directly.

The two dosing schedules

This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.

Wegovy injection, once a week

0.25 mg0.5 mg1 mg1.7 mg2.4 mg7.2 mgif needed
Wegovy’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

Wegovy tablets, once a day

1.5 mg4 mg9 mg25 mg
Wegovy’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

Saxenda, once a day

0.6 mg1.2 mg1.8 mg2.4 mg3 mg
Saxenda’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.
A smiling woman in a dark training top in her kitchen, holding a glass of water

PepVault for iPhone

Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

A missed dose, on each label

  • Wegovy: For a missed injection, the label looks at the next scheduled dose: more than 2 days away, take the missed one as soon as possible; less than 2 days away, skip it. Missing 2 or more weeks in a row means starting the climb again from a lower dose.
  • Saxenda: If a day is missed, the label goes on with the next scheduled dose and never doubles up.

The trial evidence

Questions

What is the difference between Wegovy and Saxenda?

Wegovy is semaglutide, a GLP-1 receptor agonist; Saxenda is liraglutide, a GLP-1 receptor agonist. Their labels approve them for different uses and set different schedules.

What are Wegovy and Saxenda approved for?

Wegovy is approved for weight loss and keeping it off, lowering heart risk in adults with heart disease and excess weight, and (the injection) the liver disease MASH. Saxenda is approved for weight loss and keeping it off, in adults and in children 12 and older with obesity.

How often are Wegovy and Saxenda taken?

Wegovy is taken once a week or once a day, as an injection or a tablet; Saxenda once a day, as an injection.

What are the dose ranges of Wegovy and Saxenda?

On their labels, Wegovy runs 0.25 mg to 7.2 mg once a week or 1.5 mg to 25 mg once a day, and Saxenda 0.6 mg to 3 mg once a day. A prescriber sets the actual dose.

What is the most common side effect of Wegovy and Saxenda?

On Wegovy’s label: nausea, 44% on 2.4 mg (placebo 16%). On Saxenda’s: nausea, 39.3% on Saxenda (placebo 13.8%).

Sources

PepVault is not affiliated with Novo Nordisk. Wegovy is a trademark of its owner. Saxenda is a trademark of its owner.

PepVault for iPhone

Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo